Global Infection Control Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Infection control stops or prevents the spread of infections in healthcare settings. The infections are basically caused by bacteria, fungi, viruses, stomach and intestinal infections, eye infections, ear infections, etc. These infections can be controlled by sterilization, cleaning and disinfection products, and protective barriers, endoscope reprocessing products, etc. Increasing incidences of chronic disorders are likely to enhance the market growth in the forecast period. According to the American College of Cardiology in 2019, the number of cardiovascular diseases is incessantly growing. Approximately one-third of the total deaths are caused by cardiovascular disease. In 2019, there were around 523 million new cases. Cardiovascular diseases are estimated to increase rapidly in the coming years due to growing aging population. Growing geriatric population is another major factor boosting the market growth. Whereas, rising incidence of hospital-acquired infections and favorable initiatives by market players create lucrative opportunities for the market. However, threat of the adverse effects of chemical disinfections impedes the growth of the market over the forecast period.
The key regions considered for the global Infection Control market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific is projected as the leading region across the world in terms of huge market share due to the increasing incidences of hospital acquired infections, rising adoption of sterilization and disinfection equipment, etc.
Whereas, Asia-Pacific is also estimated to attain a maximum growth rate during the forecast period. Factors such as rising threat of infections, growing geriatric population, and increasing R&D activities would create beneficial growth forecasts for the Infection Control market across Asia-Pacific region.
Major market players included in this report are:
3M Company
Belimed AG
Halyard Health, Inc.
Getinge Group
Advanced Sterilization Products
Matachana Group
Sterigenics International
MMM Group
Cantel Medical Corporation
STERIS Corporation
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Service:
Sterilization
Cleaning & Disinfection Products
Protective Barriers
Endoscope Reprocessing Products
By End-User:
Hospitals & Clinics
Pharmaceutical & Medical Device Companies
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the Global Infection Control Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors